Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cannabidiol in heart failure
NCT03634189Phase 1Unknown
- Sponsor
- Hospital Zambrano Hellion
- Start
- Mar 2021
- Primary completion
- Sep 2021
- Modality
- Small Molecules
01
Overview
Phase 1, open-label trial of cannabidiol in heart failure (HF), sponsored by Hospital Zambrano Hellion. Primary endpoint: Serious Adverse Events at 6 months. Status: unknown.
02
Drugs
cannabidiol
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT03634189.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03634189.